Viking Holdings Ltd. VIK 深 滬
已收盤 10-17 16:00:00 美东时间
60.76
+0.600
+1.00%
華盛通- 最 高60.805
- 今 開60.03
- 成交量 145.07万股
- 最 低 59.35
- 昨 收 60.16
- 總市值 269.17亿
- 52周最高 65.37
- 市盈率 靜 172.17
- 換手率 0.33%
- 52周最低 31.79
- 委 比 0.00%
- 總股本 4.43亿
- 歷史最高 65.37
- 量 比 0.74
- 振 幅 2.42%
- 歷史最低 25.71
- 每 手 1
- 風險率 2.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Vikram Solar Releases Q2FY26 Investor Presentation
An update from Vikram Solar Limited ( ($IN:VIKRAMSOLR) ) is now available. Vikr...
10-17 02:32
Viking takes delivery of newest river ships
Viking Holdings (NYSE:VIK) has taken delivery of two new river ships with itineraries that include Central and Eastern Europe, and the Nile River. The Viking Honir is the newest longship with the capa...
10-15 04:51
Viking Delivers Its Viking Honir River Ship
LOS ANGELES--(BUSINESS WIRE)-- Viking® (www.viking.com) (NYSE:VIK) today announced the delivery of its newest river ships, the Viking Honir, which will sail the Rhine, Main and Danube Rivers, and the Viking Thoth,
10-15 04:17
Shares of cruise stocks are trading higher. The sector may be seeing strength in reaction to the decrease of the price of oil.
Shares of cruise stocks are trading higher. The sector may be seeing strength i...
10-14 23:56
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
10 Analysts Have This To Say About Viking Holdings
Across the recent three months, 10 analysts have shared their insights on Vikin...
10-10 21:01
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/ -- USA News Group News Commentary – Major pharmaceutical companies are unveilin...
10-07 21:00
Studsvik Partners to Develop Sweden’s First Nuclear-Powered Data Centers
Studsvik AB ( ($SE:SVIK) ) just unveiled an update. Studsvik AB, in collaborati...
10-06 14:29
美股大行评级 | 潜在涨幅1176.6%！Ascendiant Capital上调Society Pass目标价至18美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从15美元升至18美元；Ascendiant Capital：维持Surgepays"买入"评级，目标价从9美元升至9.5美元
10-06 08:35
